Results for tag: "Wegener Granulomatosis Drug"

Wegener Granulomatosis (WG) is a rare autoimmune disorder that affects the blood vessels and can cause inflammation in the lungs, sinuses, and kidneys. Treatment for WG typically involves a combination of drugs, including corticosteroids, immunosuppressants, and biologic agents. Cardiovascular drugs are used to treat the symptoms of WG, such as inflammation, pain, and fatigue. These drugs can also help to reduce the risk of complications, such as organ damage and stroke. The Wegener Granulomatosis Drug market is composed of a variety of pharmaceutical companies that specialize in the development and manufacture of drugs for the treatment of WG. These companies include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are focused on developing new treatments and improving existing therapies for WG. Show Less Read more